% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • jiafli jiafli Feb 22, 2013 11:42 AM Flag

    IMGN is going up from here...

    (1) IMGN earning report in April will reflect FDA approval milestone payment (2) In 2 weeks, Genentech will be aggressively marketing T-DM1= more royalty payment for IMGN. Most likely sales figures will blow past analysts predictions (3) EU approval is expected before year end (4) IMGN will have data to support T-DM1 for 1st line use= more revenue= more royalties. Now that T-DM1 is approved, IMGN will be on everyone's radar.

2.78-0.03(-1.07%)Jul 26 4:00 PMEDT